×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZURA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/27
06:30 am
zura
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Low
Report
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
2/25
06:30 am
zura
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
High
Report
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
2/24
04:01 pm
zura
Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
High
Report
Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
2/23
06:30 am
zura
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
Medium
Report
Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors
2/9
07:00 am
zura
Zura Bio (NASDAQ:ZURA) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
Medium
Report
Zura Bio (NASDAQ:ZURA) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
2/4
06:30 am
zura
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Medium
Report
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
1/21
08:50 am
zura
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
High
Report
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
1/13
04:06 am
zura
Zura Bio (NASDAQ:ZURA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Neutral
Report
Zura Bio (NASDAQ:ZURA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2025
06:30 am
ZURA
zura bio limited - class a ordinary shares
MISS
Report
-9.4%
zura bio limited - class a ordinary shares
8/14/2025
08:15 am
ZURA
zura bio limited - class a ordinary shares
BEAT
Report
8.2%
zura bio limited - class a ordinary shares
5/8/2025
06:30 am
ZURA
zura bio limited - class a ordinary shares
MISS
Report
2.4%
zura bio limited - class a ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/26
08:43 am
zura
Form 8-K/A Zura Bio Ltd For: Feb 24
Medium
Report
Form 8-K/A Zura Bio Ltd For: Feb 24
2/26
06:05 am
zura
Form 8-K Zura Bio Ltd For: Feb 24
Medium
Report
Form 8-K Zura Bio Ltd For: Feb 24
2/24
09:14 pm
zura
Form 4 Zura Bio Ltd For: Feb 21 Filed by: Eisner Mark
Medium
Report
Form 4 Zura Bio Ltd For: Feb 21 Filed by: Eisner Mark
2/24
09:13 pm
zura
Form 3 Zura Bio Ltd For: Feb 21 Filed by: Eisner Mark
Medium
Report
Form 3 Zura Bio Ltd For: Feb 21 Filed by: Eisner Mark
2/23
06:41 am
zura
Form 8-K Zura Bio Ltd For: Feb 21
Medium
Report
Form 8-K Zura Bio Ltd For: Feb 21
2/17
04:16 pm
zura
Form SCHEDULE 13G/A Zura Bio Ltd Filed by: GREAT POINT PARTNERS LLC
Low
Report
Form SCHEDULE 13G/A Zura Bio Ltd Filed by: GREAT POINT PARTNERS LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: